StreetInsider.com News Articles

Form DEFC14A Seer, Inc. Filed by: Radoff Bradley Louis

Mon, 01 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26584892.html

Form DEFC14A Seer, Inc. Filed by: Radoff Bradley Louis

Mon, 01 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26584892.html

Seer files patent complaint against Nanomics at trade commission

Fri, 29 May 2026 07:21:44 -0400

Seer Inc. (NASDAQ: SEER) filed a complaint with the United States International Trade Commission against Nanomics Biotechnology Co., Ltd., seeking to bar the importation of Nanomics' Proteonano kits and workstations. The Brigham and Women's Hospital joined the complaint as a co-plaintiff.

The ITC filing follows a patent infringement lawsuit filed in federal district court on May 12. The complaint alleges Nanomics infringed five U.S. patents related to nanoparticle protein enrichment technology: Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948.

Seer requests the ITC investigate Nanomics' importation and sale of its products and issue an exclusion order preventing these products from entering the

Seer Files ITC Complaint Against Nanomics

Fri, 29 May 2026 07:00:00 -0400

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

REDWOOD CITY, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a complaint at the United States International Trade Commission (ITC) against Nanomics Biotechnology Co., Ltd. The Brigham and Women's Hospital has joined the ITC complaint as well.

The ITC complaint builds on the patent infringement suit filed in federal district court on May 12, 2026, and is based on Nanomics' infringement of U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222,

Seer Files ITC Complaint Against Nanomics

Fri, 29 May 2026 07:00:00 -0400

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

Seer Files ITC Complaint Against Nanomics

Fri, 29 May 2026 07:00:00 -0400

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

Seer Files ITC Complaint Against Nanomics

Fri, 29 May 2026 07:00:00 -0400

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

Form DFAN14A Seer, Inc. Filed by: Radoff Bradley Louis

Wed, 27 May 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260527/26559177.html

Form DFAN14A Seer, Inc. Filed by: Radoff Bradley Louis

Wed, 27 May 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260527/26559177.html

Radoff-JEC Group files proxy statement to elect directors at SEER

Wed, 27 May 2026 16:30:52 -0400

The Radoff-JEC Group, which owns approximately 7.8% of Seer Inc. (NASDAQ: SEER), filed a preliminary proxy statement to nominate three directors for election at the company's 2026 annual meeting. The group seeks to replace current board members with Howard H. Berman, Joshua S. Horowitz and Luis E. Rinaldini.

The activist investor group has made three acquisition proposals for Seer since April, most recently offering $2.40 per share in cash plus a contingent value right allowing shareholders to receive 80% of net proceeds from asset sales. The group states this represents a 42% premium to the unaffected share price of $1.69.

Seer's board

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders